SyntekaBio, Inc. (KOSDAQ:226330)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Medical Labs & Research		123.41M	243.99M	316.66M	609.68M
Medical Labs & Research Growth		-49.42%	-22.95%	-48.06%	-
Total		123.41M	243.99M	316.66M	609.68M
Total Growth		-49.42%	-22.95%	-48.06%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
South Korea		123.41M	243.99M	316.66M	609.68M
South Korea Growth		-49.42%	-22.95%	-48.06%	-
Total		123.41M	243.99M	316.66M	609.68M
Total Growth		-49.42%	-22.95%	-48.06%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error